567 related articles for article (PubMed ID: 26457012)
1. Challenges of deciphering gastric cancer heterogeneity.
Hudler P
World J Gastroenterol; 2015 Oct; 21(37):10510-27. PubMed ID: 26457012
[TBL] [Abstract][Full Text] [Related]
2. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
3. Novel biomarkers for the identification and targeted therapy of gastric cancer.
Liu L; Cao L; Gong B; Yu J
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation as a molecular biomarker in gastric cancer.
Tahara T; Arisawa T
Epigenomics; 2015; 7(3):475-86. PubMed ID: 26077432
[TBL] [Abstract][Full Text] [Related]
5. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.
Zhou J; Wang W; Xie Y; Zhao Y; Chen X; Xu W; Wang Y; Guan Z
PLoS One; 2016; 11(1):e0146521. PubMed ID: 26745502
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
10. Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric Cancer.
Hudler P
Curr Cancer Drug Targets; 2018; 18(1):65-88. PubMed ID: 28176656
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.
Jiang C; Chen X; Alattar M; Wei J; Liu H
Cancer Gene Ther; 2015 Jun; 22(6):291-301. PubMed ID: 25998522
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
13. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
[TBL] [Abstract][Full Text] [Related]
15. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
18. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.
Maekita T; Nakazawa K; Mihara M; Nakajima T; Yanaoka K; Iguchi M; Arii K; Kaneda A; Tsukamoto T; Tatematsu M; Tamura G; Saito D; Sugimura T; Ichinose M; Ushijima T
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):989-95. PubMed ID: 16467114
[TBL] [Abstract][Full Text] [Related]
19. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT
Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the molecular diagnostics of gastric cancer.
Kanda M; Kodera Y
World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
